| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |